Sensation of abdominal pain induced by peritoneal carcinomatosis is accompanied by changes in the expression of substance p and μ-opioid receptors in the spinal cord of mice

Anesthesiology

Volumn 117, Issue 4, 2012, Pages 847-856

  Suzuki, Masami ^a   Narita, Minoru ^b   Hasegawa, Minami ^b   Furuta, Sadayoshi ^b   Kawamata, Tomoyuki ^c   Ashikawa, Maho ^b   Miyano, Kanako ^a   Yanagihara, Kazuyoshi ^d   Chiwaki, Fumiko ^a   Ochiya, Takahiro ^a   Suzuki, Tsutomu ^b   Matoba, Motohiro ^a   Sasaki, Hiroki ^a   Uezono, Yasuhito ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d YASUDA WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MU OPIATE RECEPTOR; PROTEIN C FOS; SUBSTANCE P;

ABDOMINAL PAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MECHANICAL STIMULATION; MOUSE; NERVE CELL; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; SPINAL GANGLION; STOMACH CANCER; TUMOR SEEDING; VISCERAL PAIN; WITHDRAWAL SYNDROME;

ABDOMINAL PAIN; ANIMALS; BEHAVIOR, ANIMAL; CALCITONIN GENE-RELATED PEPTIDE; CARCINOMA; CELL LINE; CELL LINE, TUMOR; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUCIFERASES; MICE; MICE, INBRED ICR; MICE, SCID; NEOPLASM TRANSPLANTATION; PANCREATITIS; PROTO-ONCOGENE PROTEINS C-FOS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, OPIOID, MU; SPINAL CORD; SUBSTANCE P;

EID: 84866732637     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31826a4ac8     Document Type: Article

References (53)

1. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J: Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol 2007; 18:1437-49 (Pubitemid 47365475)
2. Hall EJ, Sykes NP: Analgesia for patients with advanced disease: I. Postgrad Med J 2004; 80:148-54 (Pubitemid 38388649)
3. Portenoy RK: Treatment of cancer pain. Lancet 2011; 377: 2236-47
4. WHO: Cancer Pain Relief, 2nd edition. Geneva, World Health Organisation, 1996
5. Jayne D: Peritoneal Carcinomatosis: A Multidisciplinary Approach. New York, Springer Science Business Media, 2006, pp 21-33
6. Cervero F: Sensory innervation of the viscera: Peripheral basis of visceral pain. Physiol Rev 1994; 74:95-138 (Pubitemid 24045675)
7. Pacharinsak C, Beitz A: Animal models of cancer pain. Comp Med 2008; 58:220-33 (Pubitemid 351954728)
8. Schwei MJ, Honore P, Rogers SD, Salak-Johnson JL, Finke MP, Ramnaraine ML, Clohisy DR, Mantyh PW: Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci 1999; 19:10886-97 (Pubitemid 30235733)
9. Lindsay TH, Jonas BM, Sevcik MA, Kubota K, Halvorson KG, Ghilardi JR, Kuskowski MA, Stelow EB, Mukherjee P, Gendler SJ, Wong GY, Mantyh PW: Pancreatic cancer pain and its correlation with changes in tumor vasculature, macrophage infiltration, neuronal innervation, body weight and disease progression. Pain 2005; 119:233-46 (Pubitemid 41752984)
10. Nagamine K, Ozaki N, Shinoda M, Asai H, Nishiguchi H, Mitsudo K, Tohnai I, Ueda M, Sugiura Y: Mechanical allodynia and thermal hyperalgesia induced by experimental squamous cell carcinoma of the lower gingiva in rats. J Pain 2006; 7:659-70 (Pubitemid 44291602)
11. Honore P, Luger NM, Sabino MA, Schwei MJ, Rogers SD, Mach DB, O'keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW: Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med 2000; 6:521-8 (Pubitemid 30305901)
12. Niiyama Y, Kawamata T, Yamamoto J, Furuse S, Namiki A: SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain. Br J Anaesth 2009; 102:251-8
13. Furuse S, Kawamata T, Yamamoto J, Niiyama Y, Omote K, Watanabe M, Namiki A: Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain. ANESTHESIOLOGY 2009; 111:173-86
14. Sevcik MA, Jonas BM, Lindsay TH, Halvorson KG, Ghilardi JR, Kuskowski MA, Mukherjee P, Maggio JE, Mantyh PW: Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer. Gastroenterology 2006; 131: 900-10 (Pubitemid 44316822)
15. Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16:109-10 (Pubitemid 13058546)
16. Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y, Toge T, Sugano K, Hirohashi S: Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci 2004; 95:575-82 (Pubitemid 39089638)
17. Yanagihara K, Takigahira M, Tanaka H, Komatsu T, Fukumoto H, Koizumi F, Nishio K, Ochiya T, Ino Y, Hirohashi S: Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci 2005; 96:323-32 (Pubitemid 41007466)
18. Yanagihara K, Takigahira M, Takeshita F, Komatsu T, Nishio K, Hasegawa F, Ochiya T: A photon counting technique for quantitatively evaluating progression of peritoneal tumor dissemination. Cancer Res 2006; 66:7532-9 (Pubitemid 44289208)
19. Kawabata A, Matsunami M, Tsutsumi M, Ishiki T, Fukushima O, Sekiguchi F, Kawao N, Minami T, Kanke T, Saito N: Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice. Br J Pharmacol 2006; 148:54-60 (Pubitemid 43675600)
20. Takemura Y, Furuta S, Hirayama S, Miyashita K, Imai S, Narita M, Kuzumaki N, Tsukiyama Y, Yamazaki M, Suzuki T, Narita M: Upregulation of bradykinin receptors is implicated in the pain associated with caerulein-induced acute pancreatitis. Synapse 2011; 65:608-16
21. Narita M, Shimamura M, Imai S, Kubota C, Yajima Y, Takagi T, Shiokawa M, Inoue T, Suzuki M, Suzuki T: Role of interleukin- 1- and tumor necrosis factor-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice. Neuroscience 2008; 152: 477-86
22. Narita M, Suzuki M, Narita M, Niikura K, Nakamura A, Miyatake M, Aoki T, Yajima Y, Suzuki T: Involvement of spinal metabotropic glutamate receptor 5 in the development of tolerance to morphine-induced antinociception. J Neurochem 2005; 94:1297-305 (Pubitemid 41232585)
23. Kasai S, Yamamoto H, Kamegaya E, Uhl GR, Sora I, Watanabe M, Ikeda K: Quantitative detection of - opioid receptor: Western blot analyses using - opioid receptor knockout mice. Curr Neuropharmacol 2011; 9:219-22
24. Shimoyama M, Tatsuoka H, Ohtori S, Tanaka K, Shimoyama N: Change of dorsal horn neurochemistry in a mouse model of neuropathic cancer pain. Pain 2005; 114:221-30 (Pubitemid 40279104)
25. Yamamoto J, Kawamata T, Niiyama Y, Omote K, Namiki A: Down-regulation of - opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain. Neuroscience 2008; 151:843-53
26. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(- C(T)) method. Methods 2001; 25:402-8 (Pubitemid 34164012)
27. Mercadante S: Malignant bone pain: Pathophysiology and treatment. Pain 1997; 69:1-18 (Pubitemid 27081402)
28. Vecht CJ: Cancer pain: A neurological perspective. Curr Opin Neurol 2000; 13:649-53 (Pubitemid 32002646)
29. Forman AD: Peripheral neuropathy and cancer. Curr Oncol Rep 2004; 6:20-5 (Pubitemid 38898826)
30. Cherny NI: How to deal with difficult pain problems. Ann Oncol 2005; 16(Suppl 2):ii79-87 (Pubitemid 40908940)
31. Todd AJ, Koerber R: Neuroanatomical substrates of spinal nociception, Wall and Melzack's Textbook of Pain, 5th edition. London, Elsevier, 2006, pp 73-90
32. Ma QP, Woolf CJ: Basal and touch-evoked fos-like immunoreactivity during experimental inflammation in the rat. Pain 1996; 67:307-16 (Pubitemid 26375346)
33. Coggeshall RE: Fos, nociception and the dorsal horn. Prog Neurobiol 2005; 77:299-352 (Pubitemid 41815592)
34. Castellanos DA, Daniels LA, Morales MP, Hama AT, Sagen J: Expansion of formalin-evoked Fos-immunoreactivity in rats with a spinal cord injury. Neurosci Res 2007; 58:386-93 (Pubitemid 47198913)
35. Craig AD, Kniffki KD: Spinothalamic lumbosacral lamina I cells responsive to skin and muscle stimulation in the cat. J Physiol 1985; 365:197-221 (Pubitemid 15243746)
36. Mense S: Nociception from skeletal muscle in relation to clinical muscle pain. Pain 1993; 54:241-89 (Pubitemid 23259287)
37. Ahmed M, Bjurholm A, Schultzberg M, Theodorsson E, Kreicbergs A: Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis: A combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum 1995; 38:699-709
38. Donnerer J, Schuligoi R, Stein C: Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992; 49:693-8
39. Nahin RL, Ren K, De León M, Ruda M: Primary sensory neurons exhibit altered gene expression in a rat model of neuropathic pain. Pain 1994; 58:95-108
40. Sommer C, Myers RR: Neurotransmitters in the spinal cord dorsal horn in a model of painful neuropathy and in nerve crush. Acta Neuropathol 1995; 90:478-85
41. Honore P, Rogers SD, Schwei MJ, Salak-Johnson JL, Luger NM, Sabino MC, Clohisy DR, Mantyh PW: Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000; 98:585-98 (Pubitemid 30408178)
42. Perry MJ, Lawson SN: Differences in expression of oligosaccharides, neuropeptides, carbonic anhydrase and neurofilament in rat primary afferent neurons retrogradely labelled via skin, muscle or visceral nerves. Neuroscience 1998; 85:293-310 (Pubitemid 28228432)
43. Munoz M, Covenas R: NK-1 receptor antagonists: A new paradigm in pharmacological therapy. Curr Med Chem 2011; 18:1820-31
44. Laird JM, Olivar T, Roza C, De Felipe C, Hunt SP, Cervero F: Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene. Neuroscience 2000; 98:345-52 (Pubitemid 30347298)
45. Tuluc F, Lai JP, Kilpatrick LE, Evans DL, Douglas SD: Neurokinin 1 receptor isoforms and the control of innate immunity. Trends Immunol 2009; 30:271-6
46. Lee YW, Chaplan SR, Yaksh TL: Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci Lett 1995; 199:111-4
47. Ossipov MH, Lopez Y, Nichols ML, Bian D, Porreca F: Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury. Neurosci Lett 1995; 199:83-6
48. Kohno T, Ji RR, Ito N, Allchorne AJ, Befort K, Karchewski LA, Woolf CJ: Peripheral axonal injury results in reduced - opioid receptor pre- and post-synaptic action in the spinal cord. Pain 2005; 117:77-87 (Pubitemid 41764774)
49. Narita M, Imai S, Nakamura A, Ozeki A, Asato M, Rahmadi M, Sudo Y, Hojo M, Uezono Y, Devi LA, Kuzumaki N, Suzuki T: Possible involvement of prolonging spinal -opioid receptor desensitization in the development of antihyperalgesic tolerance to -opioids under a neuropathic pain-like state. Addict Biol 2011 [Epub ahead of print]
50. Ji RR, Zhang Q, Law PY, Low HH, Elde R, Hökfelt T: Expression of -, -, and -opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 1995; 15:8156-66
51. Maekawa K, Minami M, Masuda T, Satoh M: Expression of - and -, but not -, opioid receptor mRNAs is enhanced in the spinal dorsal horn of the arthritic rats. Pain 1996; 64:365-71 (Pubitemid 26130873)
52. Luger NM, Sabino MA, Schwei MJ, Mach DB, Pomonis JD, Keyser CP, Rathbun M, Clohisy DR, Honore P, Yaksh TL, Mantyh PW: Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer versus inflammatory pain. Pain 2002; 99:397-406 (Pubitemid 35284270)
53. Silbert SC, Beacham DW, McCleskey EW: Quantitative singlecell differences in -opioid receptor mRNA distinguish myelinated and unmyelinted nociceptors. J Neurosci 2003; 23: 34-42 (Pubitemid 36050402)